Back
KraneShares Value Line® Dyn Div Eq ETF Vs. Avidity Biosciences Industry Stock Comparison
Buy
53
KVLE
KraneShares Value Line® Dyn Div Eq ETF
Last Price:
26.28
Seasonality Move:
2.38%
Sell
33
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
53
KraneShares Value Line® Dyn Div Eq ETF (KVLE)
is a Buy
Is KraneShares Value Line® Dyn Div Eq ETF a Buy, Sell or Hold?
- The current KraneShares Value Line® Dyn Div Eq ETF [KVLE] share price is $26.36. The Score for KVLE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- KVLE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KVLE Stock Price Chart
What is KraneShares Value Line® Dyn Div Eq ETF's stock price today?
-
The KraneShares Value Line® Dyn Div Eq ETF share price today is $26.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KVLE is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
KVLE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 65.89 | Buy |
| Chaikin Money Flow: | 1796 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.32 - 25.96) | Buy |
| Bollinger Bands (100): | (24.07 - 25.45) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 62 | Buy |
| Chaikin Money Flow: | 402350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.19 - 44.69) | Buy |
| Bollinger Bands (100): | (30.3 - 45.36) | Buy |
KVLE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.88 | Buy |
| 20-day SMA: | 25.66 | Buy |
| 50-day SMA: | 25.27 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 25.92 | Buy |
| 20-day EMA: | 25.66 | Buy |
| 50-day EMA: | 25.3 | Buy |
| 200-day EMA: | 24.13 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.33 | Buy |
| 20-day SMA: | 42.39 | Buy |
| 50-day SMA: | 43.82 | Buy |
| 200-day SMA: | 26.96 | Buy |
| 8-day EMA: | 43.04 | Buy |
| 20-day EMA: | 42.7 | Buy |
| 50-day EMA: | 41.84 | Buy |
| 200-day EMA: | 30.49 | Buy |
KraneShares Value Line® Dyn Div Eq ETF Earnings Growth & KVLE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
KraneShares Value Line® Dyn Div Eq ETF Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||